Quest Diagnostics (DGX) | Stock Overview & Key Data
Quest Diagnostics Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $213.50 on February 27, 2026
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.15B Large-cap | 0.15% | 0.87% | -8.13% | 5.81% | 11.15% | 12.44% | 43.77% | 51.23% | 152.23% | 234.65% | 240.67% | |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 7.56% | 4.21% | -5.21% | -16.94% | -18.64% | 22.27% | -5.31% | 9.75% | 222.18% | 684.25% | 1,233.99% |
|
Danaher
DHR
|
126.39B Large-cap | 1.91% | 1.19% | -14.51% | -22.28% | -23.56% | -3.81% | -12.18% | -14.95% | 176.52% | 423.71% | 744.91% |
|
Idexx Laboratories
IDXX
|
44.66B Large-cap | -1.21% | -2.25% | -13.54% | -24.87% | -17.84% | 9.77% | 19.69% | 0.93% | 539.65% | 1,408.78% | 2,730.39% |
| 32.65B Large-cap | 17.35% | 20.39% | 14.28% | -9.25% | -2.10% | 21.10% | 14.64% | -1.72% | 196.43% | 299.44% | 433.37% | |
|
Waters
WAT
|
30.55B Large-cap | 9.83% | 23.20% | 21.06% | -6.70% | -2.63% | 9.83% | 48.23% | 20.14% | 177.19% | 308.01% | 789.75% |
Ownership & Short Interest
Calculate Your Quest Diagnostics Investment Returns
Long-Term Investment Performance Analysis
Quest Diagnostics stock price in May 2016 was $77.27, A $1,000.00 lump sum investment in Quest Diagnostics made 10 years ago would be worth approximately $2,506.41 today, representing a strong return of 150.64%. This translates to an annualized return (CAGR) of 9.61%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is DGX's 52-week high and low?
- In the last 52 weeks, Quest Diagnostics reached a high of $213.50 (on February 27, 2026) and a low of $164.65 (on July 15, 2025).
- What is the market cap and P/E ratio for DGX?
- Curious about Quest Diagnostics's size and valuation? Its market capitalization stands at 22.15B. When it comes to valuation, the P/E ratio (trailing twelve months) is 22.68, and the forward P/E (looking ahead) is 17.81.
- Does DGX pay dividends? If so, what's the yield?
- Yes, Quest Diagnostics is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.68%, and the company has paid an average of $3.23 per share annually over the past 3 years.
- Who are Quest Diagnostics's main competitors or similar companies to consider before investing?
When looking at Quest Diagnostics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 22.27% -5.31% Danaher
DHR126.39B Healthcare Diagnostics & Research -3.81% -12.18% Idexx Laboratories
IDXX44.66B Healthcare Diagnostics & Research 9.77% 19.69% Agilent Technologies
A32.65B Healthcare Diagnostics & Research 21.10% 14.64% Waters
WAT30.55B Healthcare Diagnostics & Research 9.83% 48.23% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Quest Diagnostics Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Quest Diagnostics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.54%, the Debt to Equity ratio from the most recent quarter is 82.71, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for DGX?
- Looking at Quest Diagnostics's growth, its revenue over the trailing twelve months (TTM) was $11B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.20%, and quarterly earnings saw a YoY growth of 14.50%.
- How much of DGX stock is held by insiders and institutions?
- Wondering who owns Quest Diagnostics stock? Company insiders (like executives and directors) hold about 0.42% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 99.96%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.